Comments
The board of directors of Alembic Pharmaceuticals on Wednesday approved the issue of unsecured, listed, rated, redeemable, non-convertible debentures of up to ₹300 crore on private placement basis. Shares of Alembic Pharma edged down 0.06 per cent at ₹501.75 on the BSE.
Comments
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.